Hence, we infer that MYC-driven lymphomas evade NK surveillance by blocking NK cell maturation, and inhibiting MYC is essential for reversing this developmental blockade and eliciting an NK cell-mediated response against “MYC-addicted” tumors. This evidence concerns the gene MYC and lymphoma.